FindTrial
Sign In

A study to analyze genetic polymorphism of drug metabolizing enzymes using blood samples in Korean population

A study to analyze genetic polymorphism of drug metabolizing enzymes using blood samples in Korean population

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003406
Enrollment
150
Registered
2018-12-27
Start date
2018-12-03
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Kyung Hee University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Subjects who donated blood sample and have given their written informed consent. 2. 150 cases of whole blood collected at Kyunghee Medical Center bio bank(Randomly extracted from healthy volunteers and patient blood) - Thioctic Acid Healthy volunteer blood: 36 cases - Other patient blood: 114 cases

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

MeasureTime frame
Genetic polymorphism analysis of drug metabolizing enzymes including CYP2E1—

Secondary

MeasureTime frame
Genotyping Analysis of Drug Metabolizing Enzymes such as CYP2E1 and CYP3A4 Using Pyrosequencing;Analysis of association between pharmacokinetic properties of drugs including acetaminophen and genetic polymorphism—

Countries

Korea, Republic of

Contacts

Public ContactKEUM-RAN JEONG

Kyung Hee University Hospital

jkr10237@naver.com+82-2-958-2913

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026